Introduction

41
Chronic lung infections are debilitating, highly antibiotic resistant and often lethal. They affect 42 people with chronic obstructive pulmonary disease, ventilator-associated pneumonia, HIV/AIDS 43 and the genetic disorder cystic fibrosis (CF). Chronic lung infections are caused by communities of 44 different microbial genotypes and species (Short et al., 2014) , but the formation of bacterial 45 biofilms in the airways is a key factor in producing a persistent and difficult to treat infection. CF 46 lung infections are perhaps the epitome of intractable biofilm infection: they last for decades and 47 the majority of people with CF die from respiratory failure, 50% of them before reaching middle age 48 (Elborn, 2016) . Understanding the basic in vivo microbiology of key CF pathogens is a vital step 
54
Various in vitro systems and insect or rodent hosts are used to study P. aeruginosa and to 55 determine the genetic and phenotypic variables that determine virulence and persistence.
56
However, most in vitro experiments use unstructured broth cultures, or grow biofilms that are 57 attached to abiotic surfaces and whose structure is very different from those seen in vivo (Roberts (Tyrrell and Callaghan, 2016 
71
aeruginosa grown in synthetic CF sputum upregulates an antibiotic efflux pump (Tata et al., 2016) .
72
The extent of environmental change as an infection progresses from acute to chronic is underlined
73
by the extent to which P. aeruginosa and other pathogens evolve and diversify over the course of 
164
To inoculate bronchiolar sections with bacteria, a sterile hypodermic needle (29 or 30G)
165
was lightly touched to the surface of a P. aeruginosa colony grown on an LB agar plate and then 166 used to prick the bronchiolar tissue. For mock-infection controls, tissue was pricked with a sterile 167 needle. We found that needles mounted on 1 ml insulin syringes were easy to handle safely and 168 accurately. Tissue was incubated at 37°C on a rocking platform for up to 4 days.
169
After incubation, tissue was rinsed in 1 ml phosphate buffered saline to remove loosely 
177
Bead biofilm assay
178
For each bacterial clone to be investigated, a sweep of colonies was taken from an LB agar plate, 179 inoculated into 3ml ASM and cultured overnight at 37°C on an orbital shaker. Cultures were diluted 180 to an OD600 of 0.1 in ASM and three replica 2ml aliquots transferred to 5 ml plastic universal tubes.
181
A 9x6 mm plastic bead (pony beads from www.mailorder-beads.co.uk) was added to each tube Mock-infected bronchiolar EVPL retains normal histopathology for seven days (Fig. 1a) . We used a 193 sterile hypodermic needle to transfer colony-grown cells of a standard used lab strain of P.
194
aeruginosa, PAO1, to EVPL and observed that after four days' incubation in artificial sputum 195 medium at 37°C, this strain formed dense, mucoid biofilms that are highly reminiscent of the sticky 196 plugs that occlude CF patients' bronchioles (Fig. 1b, c) . Microscopy (Fig. 1c) showed that the four 197 day old biofilm had numerous empty voids, giving it a spongy appearance: this is similar to images 
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Consistency of biofilm formation on bronchiolar EVPL versus a standard in vitro assay
226
It is important to determine how reproducible experimental results are likely to be in any 227 experimental model: more variable models will require greater sample sizes to measure microbial 228 traits of interest, or to perform experiments with adequate statistical power to reject the null 229 hypothesis. For example, if we want to test the null hypothesis that there is no difference in biofilm
230
forming ability between different genotypes, it would be helpful to know the proportion of variation 231 in biofilm formation that is due to differences among clones, as opposed to differences between 232 replica populations of the same clone cultured on different pieces of tissue. In statistical language 233 this measure of reproducibility is called the intraclass correlation coefficient -or, more informally,
234
"repeatability" -and is easily calculated from the results of a one-way analysis of variance
235
(ANOVA) (Lessells and Boag, 1987) . Therefore, we conducted an experiment with a deliberately 236 small sample size to compare the repeatability of biofilm formation by ten clinical isolates of P.
237
aeruginosa on bronchiolar EVPL and in an attachment assay using plastic beads that has become 238 a standard in vitro assay for biofilm formation (Poltak and Cooper, 2011) . We sought to determine 
242
Each of the ten CF isolates previously used was cultured in triplicate in EVPL (tissue from a single 243 lung) and in a well-establised bead biofilm assay. As can be seen from the error bars in Fig. 3, 
244
there was more within-clone variation in the bead assay than in the EVPL model. Consequently,
245
the bacterial density recovered from EVPL showed higher repeatability (0.63 vs. 0.24). This 246 allowed ANOVA to identify inter-clone differences in biofilm formation (F2,20=6.1, p<0.001 ) despite 247 the small sample size; these were not apparent in the bead assay (F2,20=2.0, p=0.104) ( Table 1) .
248
The comparative data in Fig. 3 Figure S1. Replica biofilms formed by ten CF sputum isolates and two lab strains, shown at 4 days post-inoculation after washing in saline to remove loosely-adhering cells. Tissue is pictured in a standard 24-well culture plate; as two plates were required to grow three replicates of each clone, three replica uninoculated sections were placed in each plate. Nomenclature for the CF isolates is the same as in the first published article describing the phenotypic and genetic diversity of these isolates (Darch et al., 2015) .
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